Covidien plc  

(Public, NYSE:COV)   Watch this stock  
Find more results for COV
108.07
0.00 (0.00%)
Pre-market: 108.29 +0.22 (0.20%)
Jan 26, 8:47AM EST  
NYSE real-time data - Disclaimer
Currency in USD
Range     -
52 week 65.97 - 108.57
Open     -
Vol / Avg. 100.00/3.88M
Mkt cap 49.12B
P/E 27.76
Div/yield 0.36/1.33
EPS 3.89
Shares 454.51M
Beta 1.01
Inst. own 96%
Apr 23, 2015
Q2 2015 Covidien Public Limited Company Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
Jan 22, 2015
Q1 2015 Covidien PLC Earnings Release
Jan 6, 2015
Covidien PLC Extraordinary Shareholders Meeting
Nov 5, 2014
Q4 2014 Covidien PLC Earnings Release
Nov 5, 2014
Q4 2014 Covidien PLC Earnings Call - Webcast
Nov 3, 2014
Spectranetics Conference Call To Discuss Acquisition of Stellarex Assets from Covidien - Webcast
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin 19.02% 15.59%
Operating margin 23.72% 18.69%
EBITD margin - 25.42%
Return on average assets 9.92% 8.18%
Return on average equity 20.06% 17.22%
Employees 39,500 -
CDP Score - 70 C

Address

20 Lower Hatch Street, Dublin 2
DUBLIN,
Ireland
+353-1-4381700 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Covidien Public Limited Company is a healthcare products company. The Company is engaged in the development, manufacture and sale of healthcare products for use in clinical and home settings. The Company�s brands include Kendall, Nellcor, Puritan Bennett and Valleylab, among others. It has a presence in more than 70 countries, with products sold in over 150 countries. The Company�s segments include Medical Devices and United States Medical Supplies. Medical Devices includes marketing of advanced and general surgical solutions, peripheral vascular and neurovascular therapies, patient monitoring products, and airway and ventilation products. United States Medical Supplies includes products, such as nursing care, medical surgical, SharpSafety and original equipment manufacturer (OEM) products. The Company�s products include Surgical Solutions, Vascular Therapies, Respiratory and Patient Care.

Officers and directors

Jose E. Almeida Chairman of the Board, President, Chief Executive Officer
Age: 52
Bio & Compensation  - Reuters
Bryan C. Hanson Group President, Covidien
Age: 46
Bio & Compensation  - Reuters
Brian D. King President - Emerging Markets
Age: 46
Bio & Compensation  - Reuters
John H. Masterson Senior Vice President, General Counsel
Age: 52
Bio & Compensation  - Reuters
Michael P. Dunford Senior Vice President - Human Resources
Age: 53
Bio & Compensation  - Reuters
James C. Clemmer Senior Vice President and President - Medical Supplies Business
Age: 49
Bio & Compensation  - Reuters
Amy A. McBride-Wendell Senior Vice President - Strategy and Business Development
Age: 52
Bio & Compensation  - Reuters
Michael Sgrignari Senior Vice President - Quality and Operations
Age: 50
Bio & Compensation  - Reuters
Peter L. Wehrly Senior Vice President, Group President - Developed Markets
Age: 54
Bio & Compensation  - Reuters
Richard G. Brown Jr. Vice President, Chief Accounting Officer, Corporate Controller
Age: 65
Bio & Compensation  - Reuters